Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension

Clinical Therapeutics

Volumn 20, Issue 3, 1998, Pages 527-538

  Gradman, Alan H ^a   Cutler, Neal R ^b   Davis, Pamela J ^c   Robbins, John A ^d   Weiss, Robert J ^e   Wood, Barry C ^f   Michelson, Eric L ^g  

^a WESTERN PENNSYLVANIA HOSPITAL   (United States)

^b CALIFORNIA CLINICAL TRIALS   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Ctr Hlth Serv Res in Prim Care   (United States)

^e Androscoggin Cardiology Associates   (United States)

^f Astra Merck Inc ^*

^g Astra Merck   (United States)

Author keywords

Antihypertensive therapy; Combination therapy; Enalapril; Felodipine ER; Hydrochlorothiazide; Hypertension

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; DRUG TOLERANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; SYSTOLIC BLOOD PRESSURE;

EID: 0031926622     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80062-3     Document Type: Article

References (14)

1. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. NEJM. 1993; 328:914-921.
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213: 1143-1152.
3. Julius S. The hypertension optimal treatment (HOT) study in the United States. Am J Hypertens. 1996;9:41S-44S.
4. Rosenthal T. Hypertension optimal treatment: The Israeli HOT study group. J Hum Hypertens. 1996;10(Suppl 3):S161-S164.
5. Morgan TO, Anderson A, Jones E. Comparison and interaction of low dose felodipine and enalapril in the treatment of essential hypertension in elderly subjects. Am J Hypertens. 1992;5:238-243.
6. Epstein M, Bakris G. Newer approaches to antihypertensive therapy: Use of fixed-dose combination therapy. Arch Intern Med. 1996;156:1969-1978.
7. Sica DA. Fixed-dose combination antihypertensive drugs: Do they have a role in rational therapy? Drugs. 1994;48:16-24.
8. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
9. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States. JAMA. 1997;278:1745-1748.
10. Gradman AH, Cutler NR, Davis PJ, et al. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Am J Cardiol. 1997;79:431-435.
11. Applegate WB, Cohen JD, Wolfson P, et al. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension. Am J Cardiol. 1996;78:51-55.
12. Frishman WH, Ram CVS, McMahon FG, et al. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: A randomized, double-blind, placebo-controlled, parallel-group study. J Clin Pharmacol. 1995;35:1060-1066.
13. Neutel JM, Rolf CN, Valentine SN, et al. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: The efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril, and placebo. Cardiovasc Rev Rep. 1996; 17:33-45.
14. Morgan TO, Anderson A. Hemodynamic comparisons of enalapril and felodipine and their combination. Kidney Int. 1992; 41(Suppl 36):S78-S81.